Tenax Therapeutics, Inc. Expands Board of Directors
Published: Mar 02, 2021 New Board appointments strengthen Tenax with world-class expertise in cardiovascular drug development, commercial strategy, and business development New Directors will provide significant guidance as Tenax is poised to advance its two leading drug candidates into late-stage clinical testing Transformational step as Tenax strengthens its positioning as a leading specialty pharmaceutical company focused on cardio-pulmonary therapeutics a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases ...
Source: biospace.com